Word

OMASS

Status

Registered

Status Code

700

Status Date

Tuesday, August 10, 2021

Serial Number

79294792

Registration Number

6443577

Registration Date

Tuesday, August 10, 2021

Mark Type

4000

Filing Date

Wednesday, February 26, 2020

Published for Opposition

Tuesday, May 25, 2021

Trademark Owner History

OMASS Therapeutics Limited - Original Registrant

Classifications

5 Pharmaceutical and veterinary preparations for the treatment of immune response disorders, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases, infectious diseases and cardiovascular diseases; biopharmaceutical preparations for treatment of immune response disorders, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases, infectious diseases and cardiovascular diseases; chemical, biochemical and biological preparations for medical and veterinary purposes for the treatment of immune response disorders, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases, infectious diseases and cardiovascular diseases; reagents for medical use, namely reagents for in-vitro laboratory use cells for medical or clinical use, namely cells, cell lines, and cell cultures for use in the production of proteins for therapeutic use; reagents for medical use; biological reagents for medical use; therapeutic antibodies; vaccines

42 Scientific and technological services, namely scientific research and development; laboratory research services in the field of chemistry, biochemistry, biotechnology, molecular sciences and mass spectrometry; medical and pharmacological research services; scientific research, namely, analysis and measurement of substances; analysis and measurement of molecules and characteristics; bioanalysis services; scientific imaging services; biochemical analysis; scientific research and development services; medical research; research and development in the fields of immunology, genetic conditions, oncology, immuno-oncology, ophthalmology, haematology, neurology, respiratory diseases, metabolic conditions, infectious diseases and cardiovascular diseases; pharmaceutical research and development services; biological research and analysis; biomedical research services; biotechnology research; biotechnology research, namely, biotechnology testing; chemical research and analysis; research and development of new products for others in the biotechnical, biomedical and pharmaceutical fields; research and development in the pharmaceutical field; research and development of vaccines and medicines; research and development services in the field of antibodies; research and development services in the field of antibody technology; research and development services in the field of immunology; medical laboratory services; research of pharmaceuticals; research relating to molecular sciences; research relating to pharmaceuticals; biopharmaceutical research, development and testing services; drug discovery services; drug development services; pharmaceutical drug development services; conducting early evaluations in the field of new pharmaceuticals; research and development of molecules for therapeutic purposes; consultancy, advisory and/or information services in relation to all the aforesaid services

Trademark Events

Oct 7, 2023

Change Of Name/Address Rec'd From Ib

Feb 14, 2022

Final Decision Transaction Processed By Ib

Jan 24, 2022

Final Disposition Notice Sent To Ib

Jan 24, 2022

Final Disposition Processed

Nov 10, 2021

Final Disposition Notice Created, To Be Sent To Ib

Aug 10, 2021

Registered-Principal Register

May 30, 2021

Notification Processed By Ib

May 25, 2021

Official Gazette Publication Confirmation E-Mailed

May 25, 2021

Published For Opposition

May 10, 2021

Notification Of Possible Opposition Sent To Ib

May 5, 2021

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

May 5, 2021

Notification Of Notice Of Publication E-Mailed

Apr 20, 2021

Approved For Pub - Principal Register

Apr 15, 2021

Teas/Email Correspondence Entered

Apr 14, 2021

Correspondence Received In Law Office

Apr 14, 2021

Teas Response To Office Action Received

Mar 29, 2021

Assigned To Examiner

Nov 22, 2020

Refusal Processed By Ib

Nov 2, 2020

Non-Final Action Mailed - Refusal Sent To Ib

Nov 2, 2020

Refusal Processed By Mpu

Oct 10, 2020

Non-Final Action (Ib Refusal) Prepared For Review

Oct 10, 2020

Application Filing Receipt Mailed

Oct 9, 2020

Non-Final Action Written

Oct 6, 2020

Assigned To Examiner

Oct 6, 2020

New Application Office Supplied Data Entered

Oct 1, 2020

Sn Assigned For Sect 66a Appl From Ib